ISTODAX (romidepsin) for injection - Now FDA approved; available January 2010

FDA approved for the treatment of cutaneous T-cell lymphoma (CTCL)
in patients who have received at least one prior systemic therapy

If you have questions regarding ordering ISTODAX^®, reimbursement/insurance
coverage, the status of ongoing ISTODAX^® clinical trials or if you need
additional information related to ISTODAX^®, please call 1-866-223-7145.



	Now FDA approved; expected to be available in early 2010
	FDA approved for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy If you have questions regarding ordering ISTODAX^®, reimbursement/insurance coverage, the status of ongoing ISTODAX^® clinical trials or if you need additional information related to ISTODAX^®, please call 1-866-223-7145.
	www.celgene.com